The Lancor Blockchain Platform (LBP) is being developed to overcome the inefficiencies which exist in the management of healthcare data. A major focus is to enable efficient management of early testing of commonly screened cancers, and on clear, timely, personalised communication among all participants in the healthcare system. By using our developed deep learning algorithms and implementing smart tools from partner companies, Lancor Scientific contributes to the development of healthcare to the next level.
The Lancor Blockchain Platform
The LBP comprises key technology components and services for the provision of health screening services to a wide array of public and private sector healthcare practitioners and patients. The solution is being designed and built using blockchain architecture, underpinning the data storage, in order to implement a fully GDPR-compliant early health testing and screening database that is globally accessible, tamper-proof, and fully auditable. By creating a blockchain which complies with the General Data Protection Regulations (GDPR), and which communicates securely within healthcare systems through real-time exchange of patient healthcare data, we offer all participants in the healthcare system unbridled access to sensitive healthcare data at a local, regional and national level. In so doing, patients, research organisations, public health bodies and organisations beyond, all benefit. As well as through data exchange, they interact through the use of a token – the Medici Token.
The Medici Token has been created to promote the uptake of early health testing and screening around the world. Benefits include price-reduction for early testing and screening providers through bulk-buying, cost-saving for partners through preferred access and incentives for private patients to buy Medici Tokens for their personal early testing and screening. A clear, sophisticated economy of these Medici Tokens allows both for efficient exchanges of value and data, and also a strong return for investors into Lancor Scientific.
The Lancor Foundation is being established as a registered charity in England and Wales. Its purpose is to provide a web based platform, the Lancor Foundation Website (LFW), accessible via http://www.medici.health after the ICO has closed, to support all stakeholders, from the public who would access their test results, to organisations such as the World Health Organization who would benefit from real-time access to global anonymised cancer test results data. The LFW, which is being built to leverage the power of the Lancor Blockchain Platform via APIs, will be made available to the open source community once it is developed to the level of a minimum viable product.
Along with our first screening company, Tumour Trace, come relationships with governments, healthcare providers and key opinion leaders. The value on offer from these early partners extends with time, and so there are strong pull factors for other partners as the LBP grows. Tumour Trace has a common background with Lancor Scientific, but a different focus, concentrating on novel cancer diagnostics. Tumour Trace’s technology relies on the LBP, and along with investment into Tumour Trace comes a long-standing partner for Lancor Scientific. Together, the companies have an accelerated but achievable roadmap of milestones, detailed in the White Paper.
Initial Coin Offering
Investors in the Initial Coin Offering (ICO) are funding the development of affordable early testing and screening technologies for use across the world, with a more secure return through the circulation of Medici Tokens as part of the early testing and screening reimbursement cycle. So, the excitement of the early stages of an ICO is followed by a sustained growth and maturity period, in which the use of the coins to undertake tests on the LBP itself is likely to keep the value of the Medici Tokens high. There are a number of assumptions which underpin Lancor Scientific’s strategy, and a number of risks we have analysed and mitigated. The most fundamental mitigation approach is good governance, on which all other risk reduction and mitigation tactics are built.
We have a strong, well-motivated and highly experienced team, with expertise in the technical, strategic and commercial aspects of blockchain platforms. It is backed by a number of industry experts, with whom we work closely and have built strong relationships.
Meeting a well-articulated large, growing, global market need, Lancor Scientific has a powerful blockchain-based solution which, when the strategy at the heart of this White Paper is executed, has the opportunity fundamentally to change approaches to healthcare data and so improve early diagnosis of cancer, save lives and provide better patient care.
In short, we can “Find Cancer Early” and we want you to join us in doing so